| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.84 M USD | -11.01 M USD | -12.89 M USD | -7.52 M USD | -8.60 M USD | -3.43 M USD | -5.40 M USD | — | — | -21106 USD | -45151 USD | -26173 USD |
| Depreciation & Amortization | 261679 USD | 246791 USD | 199266 USD | 118620 USD | 80748 USD | 47609 USD | 27569 USD | — | — | — | — | — |
| Stock-Based Compensation | 1.26 M USD | 1.34 M USD | 1.11 M USD | 947212 USD | — | — | 324205 USD | — | — | — | — | — |
| Capital Expenditures | 81742 USD | 120197 USD | 384117 USD | 275226 USD | 67079 USD | 122427 USD | 58352 USD | — | — | — | — | — |
| Cash Flow from Investing | -81742 USD | -120197 USD | 2.65 M USD | -3.24 M USD | -67079 USD | -122427 USD | -123352 USD | — | — | 0 USD | 0 USD | 0 USD |
| Cash Flow from Financing | 8.03 M USD | 7.27 M USD | 7.40 M USD | 12.02 M USD | 11.53 M USD | 7.32 M USD | 5.77 M USD | — | — | 21106 USD | 46784 USD | 25853 USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | -124617 USD | -81403 USD | -119419 USD | 0 USD | — | — | — | — | — | — | — | — |
| Free Cash Flow | -2.92 M USD | -11.13 M USD | -13.27 M USD | -7.79 M USD | -8.67 M USD | -3.55 M USD | -5.45 M USD | — | — | — | — | — |
NeuroOne Medical Technologies Corporation is a medical technology company that develops and markets cutting-edge neural surgical solutions. The company's primary focus lies in designing advanced electrode technology for recording and stimulating brain activity, which plays a crucial role in diagnosing and treating various neurological disorders. These electrodes are used for electroencephalography (EEG), electrocorticography (ECoG), and brain stimulation therapies, impacting sectors such as neurology, neurosurgery, and neurodiagnostics. NeuroOne's innovative products aim to address unmet needs in the medical field by providing less invasive and more cost-effective solutions for brain surgeries and therapeutic treatments. Headquartered in the United States, NeuroOne Medical Technologies Corporation is at the forefront of enhancing the capabilities of neural procedures and treatments, potentially transforming how healthcare providers approach neurological conditions.